Compare Analog Devices, Inc. (ADI) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Analog Devices, Inc. vs Sanofi SA — how do they compare? Analog Devices, Inc. trades at $361.3 (market cap $175.10B), while Sanofi SA trades at $43.41 (market cap $102.65B). The key difference: Analog Devices, Inc. is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.71%). Which is the better fit depends on your goals — on Pluang, investors hold Analog Devices, Inc. for 64 Days and Sanofi SA for 93 Days on average.
| ADI | SNY | |
|---|---|---|
Market Cap | $175.10B | $102.65B |
Volume | 2,400,553 | 2,681,965 |
Sector | Technology | Health |
52-Week High | $445.48 | $52.34 |
52-Week Low | $225.20 | $41.33 |
Typical Hold Time | 64 Days | 93 Days |
Enterprise Value | $181.89B | $122.54B |
Dividend Yield | 1.22% | 5.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADI trades at $362.04, up 0.28% today, with a bearish technical signal but strong fundamentals including a 29.79% net income margin and three consecutive quarterly earnings beats. Recent acquisitions like Alif Semiconductor for $1.35 billion (Reuters, 2026-09-09) aim to expand its AI and industrial automation footprint. Cash flow remains positive at $508 million in 2025, though net cash flow is projected negative for 2026.
Outlook is positive with a consensus price target of $480.24 (MarketBeat, 2026-09-09), offering 33% upside, but high valuation ratios (P/E 42.92) and competitive pressures pose risks. Institutional ownership is robust, with Bank of America acquiring a $3.57 billion stake (Defense World, 2026-09-15), supporting long-term growth in AI-driven markets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Analog Devices, Inc.
Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
Read more on ADI →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
